Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18808815 | CONCENTRIC ARCHITECTURE FOR OPTICAL SENSING | August 2024 | January 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 18796264 | SYSTEM FOR PRECISELY LOCATING ABNORMAL AREA OF BRAIN FIBER BUNDLE | August 2024 | February 2025 | Allow | 6 | 1 | 0 | No | No |
| 18739199 | TARGETING CORONARY REVASCULARIZATION BASED ON MYOCARDIAL VIABILITY | June 2024 | November 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18600308 | UNIFIED ANISOTROPIC VOLUME AND SURFACE MESH STORAGE | March 2024 | May 2025 | Allow | 15 | 1 | 0 | Yes | No |
| 18444367 | SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE IMAGE-BASED PLAQUE ANALYSIS AND RISK DETERMINATION | February 2024 | October 2024 | Allow | 8 | 1 | 0 | Yes | No |
| 18444339 | SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE IMAGE-BASED PLAQUE ANALYSIS AND RISK DETERMINATION | February 2024 | April 2025 | Allow | 14 | 2 | 0 | Yes | No |
| 18579311 | IMPLEMENTING A PERIODIC DEOXYHEMOGLOBIN SIGNAL | January 2024 | May 2025 | Allow | 16 | 0 | 0 | Yes | No |
| 18391515 | SYSTEM, DEVICE AND METHOD FOR SAFEGUARDING THE WELLBEING OF PATIENTS FOR FLUID INJECTION | December 2023 | December 2024 | Allow | 12 | 0 | 0 | No | No |
| 18350177 | ULTRASOUND DIAGNOSTIC APPARATUS AND OPERATION METHOD OF ULTRASOUND DIAGNOSTIC APPARATUS | July 2023 | March 2025 | Allow | 20 | 1 | 0 | No | No |
| 18350104 | SYSTEMS AND METHODS FOR ABLATION VISUALIZATION | July 2023 | September 2024 | Allow | 15 | 0 | 0 | No | No |
| 18193800 | REGISTRATION OF 3D and 2D IMAGES FOR SURGICAL NAVIGATION AND ROBOTIC GUIDANCE WITHOUT USING RADIOPAQUE FIDUCIALS IN THE IMAGES | March 2023 | October 2024 | Allow | 18 | 0 | 0 | No | No |
| 18183877 | CONNECTED BODY SURFACE CARE MODULE | March 2023 | January 2025 | Allow | 22 | 4 | 0 | Yes | No |
| 18183639 | SYSTEM AND METHOD FOR AUTOMATED TRANSFORM BY MANIFOLD APPROXIMATION | March 2023 | December 2024 | Allow | 21 | 1 | 0 | No | No |
| 18102243 | ACOUSTIC SHOCK WAVE OR PRESSURE PULSE TREATMENT FOR PROPTOSIS OR EXOPHTHALMOS | January 2023 | May 2025 | Allow | 27 | 0 | 1 | Yes | No |
| 18098032 | APPARATUS AND METHOD FOR CONTINUOUS NONINVASIVE MEASUREMENT OF LUNG FLUID RESPIRATORY FUNCTION AND EVENTS | January 2023 | October 2024 | Allow | 21 | 1 | 0 | No | No |
| 18085443 | NEEDLE AND TINE DEPLOYMENT MECHANISM | December 2022 | January 2024 | Allow | 13 | 0 | 0 | No | No |
| 18062829 | METHOD FOR PREDICTING CARDIOVASCULAR RISK | December 2022 | December 2023 | Allow | 12 | 0 | 0 | Yes | No |
| 18053560 | SYSTEMS AND METHODS FOR TOUCHLESS DETECTION OF HEART RATE VARIABILITY | November 2022 | January 2025 | Allow | 26 | 2 | 0 | No | No |
| 17921245 | SYSTEM, DEVICE AND METHOD FOR SAFEGUARDING THE WELLBEING OF PATIENTS FOR FLUID INJECTION | October 2022 | October 2023 | Allow | 11 | 1 | 0 | No | No |
| 17967302 | ULTRASOUND SYSTEMS AND METHODS FOR USER INTERFACE ON IMAGE TOUCHSCREEN CONTROL OF FOCAL ZONE ADJUSTMENTS | October 2022 | March 2025 | Allow | 29 | 2 | 0 | Yes | No |
| 17964657 | OPTICAL CAMERA POSITIONING TOOL | October 2022 | November 2024 | Allow | 25 | 1 | 0 | No | No |
| 17881932 | TREATMENT INSTRUMENT | August 2022 | May 2024 | Allow | 22 | 0 | 0 | No | No |
| 17878564 | Multimodal Imaging Systems Probes And Methods | August 2022 | January 2024 | Allow | 17 | 0 | 0 | No | No |
| 17814435 | System And Methods For Assessing Presence Of Large Vessel Occlusion To Aid In Transfer Decision-Making For Endovascular Treatment In Patients With Acute Ischemic Stroke | July 2022 | March 2024 | Allow | 20 | 1 | 0 | No | No |
| 17805533 | SYSTEMS AND METHODS FOR PREDICTIVE HEART VALVE SIMULATION | June 2022 | September 2024 | Allow | 27 | 1 | 0 | No | No |
| 17831993 | Method and System for In-Bed Contact Pressure Estimation Via Contactless Imaging | June 2022 | October 2024 | Allow | 28 | 1 | 0 | No | No |
| 17751352 | LOCALIZATION SYSTEMS AND METHODS FOR AN INGESTIBLE DEVICE | May 2022 | November 2023 | Allow | 17 | 0 | 0 | No | No |
| 17770431 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR UTILIZING A THERAPEUTIC ULTRASOUND DEVICE TO PERFORM MITRAL VALVE DECALCIFICATION | April 2022 | November 2024 | Allow | 31 | 1 | 0 | No | No |
| 17765471 | IMAGING-BASED REFLEX MEASUREMENTS FOR SEDATION DEPTH MONITORING | March 2022 | May 2025 | Allow | 38 | 2 | 1 | Yes | No |
| 17657177 | COMBINING MULTIPLE ERGONOMIC RISK FACTORS IN A SINGLE PREDICTIVE FINITE ELEMENT MODEL | March 2022 | July 2025 | Allow | 39 | 1 | 0 | Yes | No |
| 17765177 | OBJECTIVE EVALUATION OF NEUROLOGICAL MOVEMENT DISORDERS FROM MEDICAL IMAGING | March 2022 | November 2024 | Allow | 32 | 1 | 1 | Yes | No |
| 17696116 | BIOLOGICAL INFORMATION MEASUREMENT SYSTEM AND COMPUTER-READABLE MEDIUM | March 2022 | June 2024 | Abandon | 27 | 1 | 0 | No | No |
| 17690890 | SCANNING BASED THz NEARFIELD IMAGING DEVICE | March 2022 | October 2024 | Abandon | 31 | 1 | 0 | No | No |
| 17682839 | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections | February 2022 | February 2025 | Abandon | 36 | 2 | 0 | No | No |
| 17651846 | INFRARED THERMOGRAPHY PLATFORM FOR DETERMINING VASCULAR HEALTH OF INDIVIDUALS | February 2022 | April 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 17579624 | THORACIC GARMENT OF POSITIONING ELECTROMAGNETIC (EM) TRANSDUCERS AND METHODS OF USING SUCH THORACIC GARMENT | January 2022 | June 2024 | Allow | 29 | 1 | 0 | No | No |
| 17571273 | MULTI-TARGET TREATMENT PLANNING AND DELIVERY AND VIRTUAL LOCALIZATION FOR RADIATION THERAPY | January 2022 | May 2024 | Allow | 28 | 0 | 1 | Yes | No |
| 17454540 | METHOD OF ASSESSING THE LEVEL OF VASCULAR INFLAMMATION | November 2021 | September 2023 | Allow | 22 | 1 | 0 | Yes | No |
| 17504301 | ULTRASOUND THERAPY CATHETER WITH MULTI-CHAMBERED BALLOONS FOR TRANSLUMINAL LONGITUDINAL POSITIONING | October 2021 | November 2023 | Allow | 25 | 1 | 0 | Yes | No |
| 17462622 | HEART RATE DETECTING DEVICE CAPABLE OF ALLEVIATING MOTION INTERFERENCE | August 2021 | January 2025 | Allow | 41 | 1 | 0 | No | No |
| 17432909 | MEASUREMENT DEVICE USING EIT ELECTRODE | August 2021 | February 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17428011 | METHODS FOR ACCURATE NEEDLE-FREE ASSESSMENT OF MYOCARDIAL OXYGENATION | August 2021 | June 2024 | Abandon | 35 | 2 | 0 | No | No |
| 17393157 | Personal Health Data Collection | August 2021 | November 2022 | Allow | 16 | 2 | 0 | Yes | No |
| 17383327 | SYSTEMS AND METHODS FOR PREDICTING THROMBOSIS FOR HEART VALVE REPLACEMENTS | July 2021 | April 2025 | Allow | 44 | 2 | 0 | No | No |
| 17311524 | Pulse Sensor for Detecting the Pulse of a Living Organism | June 2021 | February 2025 | Allow | 44 | 0 | 1 | No | No |
| 17315691 | METHODS AND APPARATUS FOR ELECTROMAGNETIC SOURCE IMAGING USING DEEP NEURAL NETWORKS | May 2021 | February 2024 | Allow | 33 | 1 | 0 | No | No |
| 17160910 | TRAINING IMAGE GENERATION DEVICE, TRAINING IMAGE GENERATION METHOD, TRAINING IMAGE GENERATION PROGRAM, LEARNING DEVICE, LEARNING METHOD, LEARNING PROGRAM, DISCRIMINATOR, RADIOGRAPHIC IMAGE PROCESSING DEVICE, RADIOGRAPHIC IMAGE PROCESSING METHOD, AND RADIOGRAPHIC IMAGE PROCESSING PROGRAM | January 2021 | February 2024 | Allow | 37 | 2 | 1 | Yes | No |
| 17256024 | SYSTEMS AND METHODS FOR RECONSTRUCTION OF MEDICAL IMAGES | December 2020 | March 2024 | Allow | 39 | 1 | 0 | No | No |
| 17247637 | TRANSILLUMINATION OF IRIS MUSCLES TO INFER STROMA DEFORMATION | December 2020 | November 2024 | Allow | 47 | 2 | 0 | No | No |
| 17010497 | METHODS AND SYSTEMS FOR ADAPTIVE TIMING OF A SECOND CONTRAST BOLUS | September 2020 | April 2024 | Allow | 43 | 1 | 0 | No | No |
| 17006973 | INJECTION SETUP KITS AND METHODS | August 2020 | January 2024 | Allow | 40 | 1 | 0 | Yes | No |
| 16966262 | SKINCARE DEVICE | July 2020 | November 2024 | Abandon | 51 | 2 | 0 | No | No |
| 16772644 | ENDOSCOPIC IMAGING USING NANOSCALE METASURFACES | June 2020 | June 2025 | Allow | 60 | 3 | 0 | Yes | No |
| 16867509 | OPTICAL TOMOGRAPHY SENSOR AND RELATED APPARATUS AND METHODS | May 2020 | February 2025 | Abandon | 58 | 4 | 0 | Yes | No |
| 16627171 | UNIFIED ANISOTROPIC VOLUME AND SURFACE MESH STORAGE | December 2019 | January 2024 | Allow | 48 | 4 | 0 | Yes | No |
| 16681325 | CARDIAC IMAGE PROCESSING APPARATUS, SYSTEM, AND METHOD | November 2019 | April 2024 | Abandon | 53 | 3 | 1 | Yes | No |
| 16500109 | SYSTEMS AND METHODS FOR PLANNING PERIPHERAL ENDOVASCULAR PROCEDURES WITH MAGNETIC RESONANCE IMAGING | October 2019 | August 2024 | Abandon | 58 | 4 | 0 | No | Yes |
| 16492643 | CARDIAC MOTION SIGNAL DERIVED FROM OPTICAL IMAGES | September 2019 | March 2024 | Allow | 54 | 5 | 0 | No | No |
| 16488087 | METHOD AND DEVICE FOR NON-INVASIVELY CLASSIFYING A TUMOROUS MODIFICATION OF A TISSUE | August 2019 | June 2024 | Abandon | 58 | 5 | 0 | No | No |
| 16534725 | DYNAMIC AGENT INJECTION FOR CARDIOVASCULAR CHARACTERIZATION | August 2019 | January 2024 | Allow | 54 | 3 | 1 | Yes | No |
| 16410130 | Systems and Methods for Imaging of Neurovascular-Coupling | May 2019 | December 2024 | Allow | 60 | 4 | 1 | Yes | No |
| 16388218 | Use of HP Xenon-129 MRI to Measure Xenon Signal Changes in the Brain Tissue Over a Period to Quantitatively Evaluate the Condition of CBF in an Individual | April 2019 | February 2025 | Abandon | 60 | 6 | 0 | No | No |
| 16336603 | ANATOMICAL MODEL FOR POSITION PLANNING AND TOOL GUIDANCE OF A MEDICAL TOOL | March 2019 | September 2024 | Abandon | 60 | 6 | 0 | Yes | No |
| 16261994 | ULTRASOUND PRODUCTION SOURCE WITH AN OUTSIDE THREAD | January 2019 | March 2024 | Allow | 60 | 6 | 0 | Yes | No |
| 16306951 | SYSTEMS AND METHODS FOR LIGHTING IN RENDERED IMAGES | December 2018 | September 2024 | Abandon | 60 | 8 | 0 | No | No |
| 16195424 | Cardiac and Respiratory Self-Gated Motion-Corrected Free-Breathing Spiral Cine Imaging | November 2018 | September 2024 | Abandon | 60 | 6 | 0 | No | No |
| 16174585 | MEDICAL IMAGING APPARATUS TO AUTOMATICALLY DETERMINE PRESENCE OF AN ABNORMALITY INCLUDING A DETERMINATION TO TRANSMIT AN ASSISTANCE IMAGE AND A CLASSIFIED ABNORMALITY STAGE | October 2018 | February 2024 | Allow | 60 | 5 | 1 | Yes | No |
| 16077041 | SYSTEM TO DIFFERENTIATE AND IDENTIFY TYPES OF TISSUE WITHIN A REGION PROXIMATE TO A WORKING END OF A SURGICAL INSTRUMENT | August 2018 | January 2024 | Allow | 60 | 4 | 0 | No | No |
| 15332979 | APPARATUS AND METHOD FOR CONTINUOUS NONINVASIVE MEASUREMENT OF RESPIRATORY FUNCTION AND EVENTS | October 2016 | April 2018 | Abandon | 18 | 12 | 0 | No | No |
| 13922860 | INTRACORPOREAL MARKER AND MARKER DELIVERY DEVICE | June 2013 | September 2018 | Allow | 60 | 2 | 0 | No | Yes |
| 13635501 | HOLDER AND LIGHT MEASURING DEVICE USING SAME | November 2012 | February 2019 | Allow | 60 | 6 | 0 | No | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MEHL, PATRICK M.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner MEHL, PATRICK M works in Art Unit 3798 and has examined 64 patent applications in our dataset. With an allowance rate of 76.6%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.
Examiner MEHL, PATRICK M's allowance rate of 76.6% places them in the 35% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by MEHL, PATRICK M receive 2.25 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by MEHL, PATRICK M is 35 months. This places the examiner in the 22% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +16.2% benefit to allowance rate for applications examined by MEHL, PATRICK M. This interview benefit is in the 60% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 14.9% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 19.4% of cases where such amendments are filed. This entry rate is in the 16% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 85% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 44% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.